ReviewFrontiers in immunology2026
Staining patterns of autoantibodies in indirect immunofluorescence for autoimmune diseases of the digestive system: morphological characteristics and clinical significance.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoantibody detection is integral to the laboratory diagnosis of autoimmune diseases (AIDs). Notwithstanding the advent of a multiplicity of quantitative alternative methodologies, indirect immunofluorescence (IIF) remains the gold standard for the initial screening of many autoantibodies. Notably, autoimmune diseases of the digestive system present the widest variety of target autoantibodies and the most intricate fluorescence patterns, rendering them exceptionally contingent upon IIF testing. This article endeavors to furnish an exposition of autoantibodies germane to digestive system AIDs that necessitate IIF detection, meticulously delineating their fluorescent morphological characteristics and clinical significance. Given the complexity in interpreting IIF results for these specific autoantibodies, we will analyze fluorescent localization patterns based on tissue architecture, whilst disambiguating them from common confounding artifacts encountered in clinical practice. This study marks a dedicated attempt to differentiate among several antibody groups with overlapping fluorescence profiles, namely, anti-smooth muscle antibodies (ASMA), anti-elastin antibodies, and anti-reticulin antibodies (ARA); as well as antimitochondrial antibodies (AMA), anti-parietal cell antibodies (PCA), and heterophile antibodies (HA). The ultimate objective is to augment the pattern recognition and interpretive acumen of both laboratory professionals and clinicians, thereby maximizing the benefit of IIF testing in patients with suspected conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.